Sort   by:  
 Page size 
UnknownBudigalimab, an anti-PD-1 inhibitor, for people living with HIV-1: a randomized, placebo-controlled phase 1b study.
Not available
S-EPMC12618229 | biostudies-literature
UnknownDolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study.
Not available
S-EPMC3694319 | biostudies-literature
UnknownPharmacokinetics and antiviral activity of cabotegravir and rilpivirine in cerebrospinal fluid following long-acting injectable administration in HIV-infected adults.
Not available
S-EPMC7021098 | biostudies-literature
UnknownPhase IIa Proof-of-Concept Evaluation of the Antiviral Efficacy, Safety, Tolerability, and Pharmacokinetics of the Next-Generation Maturation Inhibitor GSK3640254.
Not available
S-EPMC9536290 | biostudies-literature
UnknownThigh Injections of Cabotegravir + Rilpivirine in Virally Suppressed Adults With HIV-1: A Substudy of the Phase 3b ATLAS-2M Study.
Not available
S-EPMC12314501 | biostudies-literature
UnknownWeek 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase III Randomized AMBER and EMERALD Trials.
Not available
S-EPMC6944133 | biostudies-literature
UnknownRacial differences in hepatitis C treatment eligibility.
Not available
S-EPMC3736356 | biostudies-literature
Sort   by:  
 Page size